Xianliang Luo

Dr. Xianliang Luo

College of Food Science, Fujian Agriculture and Forestry University, Fuzhou, Fujian, China
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2021 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
JWJing Wang
Jing Wang
YCYong Chen
Yong Chen
HZHao Zhong
Hao Zhong
FCFang Chen
Fang Chen
JRJoe Regenstein
Joe Regenstein
Fengqin FengFengqin Feng
Fengqin Feng
Hyperuricemia (HUA) is a metabolic disorder caused by abnormal uric acid (UA) metabolism, which is a complex physiological process involving multiple organs (liver, kidney, and intestine). Although UA metabolism in the liver and kidneys has been elucidated, only a few studies have focused on the process in the intestine. With our growing knowledge of the effects of gut microorganisms on health, the gut microbiota has been identified as a new target for HUA treatment. In this review, the relationship between HUA and the gut microbiota is elucidated, and anti-hyperuricemia mechanisms targeting the intestine are discussed, such as the promotion of purine and UA catabolism by the gut microbiota, increases in UA excretion by the gut microbiota and its metabolites, regulation of UA absorption or secretion in the intestinal tract by certain transporters, and the intestinal inflammatory response to the gut microbiota. Additionally, probiotics (Bifidobacteria and Lactobacilli) and prebiotics (polyphenols, peptides, and phytochemicals) with UA-lowering effects targeting the intestinal tract are summarized, providing reference and guidance for further research.

1 December 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XLXianliang Luo
Xianliang Luo
QWQi Wang
Qi Wang
DFDongya Fang
Dongya Fang
WZWeijing Zhuang
Weijing Zhuang
CCCanhui Chen
Canhui Chen
Yafeng ZhengYafeng Zheng
Yafeng Zheng

1 November 2017 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
XLXianliang Luo
Xianliang Luo
QWQi Wang
Qi Wang
BZBaodong Zheng
Baodong Zheng
LLLiangmei Lin
Liangmei Lin
BCBingyan Chen
Bingyan Chen
Jianbo XiaoJianbo Xiao
Jianbo Xiao

9 January 2018 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
ZJZengliang Jiang
Zengliang Jiang
MZMinjie Zhao
Minjie Zhao
Hui ZhangHui Zhang
Hui Zhang
YLYang Li
Yang Li
MLMengyun Liu
Mengyun Liu
Fengqin FengFengqin Feng
Fengqin Feng

9 September 2020 in Food & Function
Verified
Journal Article
Closed access
PDF file
HZHao Zhong
Hao Zhong
ABAbdullah
Abdullah
LDLingli Deng
Lingli Deng
MZMinjie Zhao
Minjie Zhao
JTJun Tang
Jun Tang
Fengqin FengFengqin Feng
Fengqin Feng
Blueberry dietary interventions have demonstrated remarkable potential against obesity and type 2 diabetes mellitus. However, the effects of fermented blueberry juice on metabolic syndrome, the gut microbiota, and insulin resistance have not yet been reported. This study aimed to investigate the potential of fermented blueberry juice against obesity, hyperglycemia, and gut microbiota dysbiosis in high fat diet (HFD)-fed mice. Our study findings revealed that supplementation with fresh blueberry juice (BBJ), and fermented blueberry juice with homemade probiotic starter (FBJ) or commercial starter (CFBJ) significantly decreased fat accumulation and low density lipoprotein cholesterol (LDL-C) levels in HFD-fed mice. FBJ showed relatively more potency to reduce body weight than BBJ and CFBJ. The percentage increase in the body weight of the FBJ group was almost the same as that in the normal chow diet (NCD) group, and was approximately 10% lower than the BBJ and CFBJ groups. Overall, all blueberry juices significantly ameliorated hyperlipidemia and insulin resistance in HFD-fed mice. Moreover, the dietary interventions with BBJ, FBJ, and CFBJ for 17 weeks significantly improved the community richness and diversity of the gut microflora along with an altered structure in the HFD-fed mice group. The FBJ treated mice group showed relatively low abundance of Firmicutes, obesity-related bacteria (Oscillibacter and Alistipes), and high abundance of lean bacteria (Akkermansia, Barnesiella, Olsenella, Bifidobacterium, and Lactobacillus) compared to the HFD-fed mice group. Furthermore, BBJ and FBJ treatments regulated the liver mRNA and protein expression levels involved in lipid and glucose metabolism. This study inferred that fermented blueberry juice could be used as a functional food to prevent the modern pandemics i.e., obesity and insulin resistance.

12 November 2020 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
WLWangxin Liu
Wangxin Liu
XLXianliang Luo
Xianliang Luo
JTJun Tang
Jun Tang
QMQiufen Mo
Qiufen Mo
HZHao Zhong
Hao Zhong
Fengqin FengFengqin Feng
Fengqin Feng